Fuel Tech Reports 2025 First Quarter Financial Results
Select First Quarter 2025 Highlights
Revenue rose 29% to $6.4 million
Gross margin expanded to 46.4%
Operating loss narrowed to $1.0 million
Backlog rose 66% to $10.3 million
Cash, cash equivalents and investments of $31.2 million, no long-term debt
WARRENVILLE, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported financial results for the first quarter ended March 31, 2025 ('Q1 2025').
'We are very pleased with our first quarter performance, reinforcing our belief that 2025 will be a year of growth for our Company,' Vincent J. Arnone, President and CEO. 'Consolidated revenues and gross margin each increased compared to last year's first quarter, driven by a 92% rise in FUEL CHEM® revenue. Our business development activities for our Air Pollution Control ('APC') business segment generated $5.6 million of orders from new and existing U.S. and international customers during the first quarter of 2025, and we grew our backlog by 66% to $10.3 million, the highest quarterly backlog since 2022. At March 31, 2025, our balance sheet remained strong, with $31.2 million in cash, cash equivalents and investments and no long-term debt.
'We expect continued strong performance from our FUEL CHEM segment throughout 2025, driven by the return to full operation of our base accounts and the incremental contribution from the new commercial account that we added in the fourth quarter of 2024. We continue to pursue additional FUEL CHEM opportunities domestically and internationally, and we expect that a new demonstration of our TIFI® Targeted In-Furnace Injection™ technology is likely to commence late in the third quarter of this year at a coal-fired unit in the Midwest.'
Mr. Arnone continued, 'While APC revenues decreased compared to last year's first quarter, we have been encouraged by the cadence of new contract awards and business development opportunities, which will ultimately benefit segment performance as we execute these contracts. We are continuing to pursue additional new awards driven by industrial expansion globally and by state-specific regulatory requirements in the U.S., and hope to have those in hand late in the current second quarter. We are also participating in larger domestic contract opportunities to support emissions control requirements for the development of data centers, utilizing our SCR and ULTRA® technologies.'
Mr. Arnone concluded, 'We expect to commence an extended demonstration of our Dissolved Gas Infusion (DGI®) technology at a fish hatchery in the Western U.S late in the second quarter of 2025. We continue to receive inquiries regarding DGI from potential customers in multiple end markets and we are hopeful that we can generate our first commercial revenues in 2025.'
Q1 2025 Consolidated Results Overview
Consolidated revenues for Q1 2025 rose 29% to $6.4 million from $5.0 million in Q1 2024, driven by a 92% increase in FUEL CHEM revenue. This increase was offset by a 44% revenue decline in APC segment revenues.
Consolidated gross margin for Q1 2025 increased to 46.4% of revenues from 40.9% of revenues in Q1 2024, reflecting an increase in FUEL CHEM gross margin and the relative contribution of FUEL CHEM versus APC revenue, partially offset by a decrease in APC gross margin.
SG&A expenses were flat at $3.3 million for Q1 2025 and Q1 2024. As a percentage of revenues, SG&A expenses declined to 52.4% in Q1 2025 from 67.5% in Q1 2024, reflecting higher revenues.
Interest income was stable at $0.3 million and related primarily to interest received on the held-to-maturity debt securities and money market funds.
Net loss in Q1 2025 was $(739,000), or $(0.02) per share, compared to net income of $281,000, or $0.01 per share, in Q1 2024. Net income in Q1 2024 included a one-time other income amount of $1.7 million related to the employee retention credit. Excluding this one-time other income amount, net loss for Q1 2024 was $(1.4) million, or $(0.05) per share.
Consolidated APC segment backlog at March 31, 2025 rose 66% to $10.3 million from $6.2 million at December 31, 2024.
APC segment revenue decreased to $1.3 million from $2.3 million in Q1 2024, primarily related to timing of project execution on existing contracts. Segment gross margin declined to 32.6% from 38.4%, reflecting lower segment revenues.
FUEL CHEM segment revenue rose 92% to $5.1 million from $2.6 million in Q1 2024, primarily due to outage completions and increased dispatch, as well as sustained business from a new customer account added midyear in 2024. Segment gross margin expanded to 49.9% from 43.2% in Q1 2024, reflecting higher segment revenues.
Adjusted EBITDA loss was $(0.7) million in Q1 2025 compared to Adjusted EBITDA loss of $(1.5) million in Q1 2024.
Financial Condition
At March 31, 2025, cash and cash equivalents were $11.8 million, short-term investments were $10.0 million, and long-term investments totaled $9.4 million. Stockholders' equity at March 31, 2025 was $41.4 million, or $1.35 per share, and the Company had no debt.
Conference Call
Management will host a conference call on Tuesday, May 13, 2025 at 10:00 am ET / 9:00 am CT to discuss the results and business activities. Interested parties may participate in the call by dialing:
(877) 423-9820 (Domestic) or
(201) 493-6749 (International)
The conference call will also be accessible via the Upcoming Events section of the Company's web site at www.ftek.com. Following management's opening remarks, there will be a question-and-answer session. Questions may be asked during the live call, or alternatively, you may e-mail questions in advance to dsullivan@equityny.com. For those who cannot listen to the live broadcast, an online replay will be available at www.ftek.com.
About Fuel Tech
Fuel Tech develops and commercializes state-of-the-art proprietary technologies for air pollution control, process optimization, water treatment, and advanced engineering services. These technologies enable customers to operate in a cost-effective and environmentally sustainable manner. Fuel Tech is a leader in nitrogen oxide (NOx) reduction and particulate control technologies and its solutions have been installed on over 1,300 utility, industrial and municipal units worldwide. The Company's FUEL CHEM® technology improves the efficiency, reliability, fuel flexibility, boiler heat rate, and environmental status of combustion units by controlling slagging, fouling, corrosion and opacity. Water treatment technologies include DGI® Dissolved Gas Infusion Systems which utilize a patented saturator and a patent-pending channel injector to deliver supersaturated oxygen solutions and other gas-water combinations to target process applications or environmental issues. This infusion process has a variety of applications in the water and wastewater industries, including remediation, aeration, biological treatment and wastewater odor management. Many of Fuel Tech's products and services rely heavily on the Company's exceptional Computational Fluid Dynamics modeling capabilities, which are enhanced by internally developed, high-end visualization software. For more information, visit Fuel Tech's web site at www.ftek.com.
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains 'forward-looking statements' as defined in Section 21E of the Securities Exchange Act of 1934, as amended, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and reflect Fuel Tech's current expectations regarding future growth, results of operations, cash flows, performance and business prospects, and opportunities, as well as assumptions made by, and information currently available to, our management. Fuel Tech has tried to identify forward-looking statements by using words such as 'anticipate,' 'believe,' 'plan,' 'expect,' 'estimate,' 'intend,' 'will,' and similar expressions, but these words are not the exclusive means of identifying forward-looking statements. These statements are based on information currently available to Fuel Tech and are subject to various risks, uncertainties, and other factors, including, but not limited to, contracts being awarded to competitors offering different or lower-priced technologies, projects being suspended, delayed or cancelled and other risks discussed in Fuel Tech's Annual Report on Form 10-K in Item 1A under the caption 'Risk Factors,' and subsequent filings under the Securities Exchange Act of 1934, as amended, which could cause Fuel Tech's actual growth, results of operations, financial condition, cash flows, performance and business prospects and opportunities to differ materially from those expressed in, or implied by, these statements. Fuel Tech undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances or for any other reason. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in Fuel Tech's filings with the Securities and Exchange Commission.
FUEL TECH, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands, except share and per share data)
March 31,
December 31,
2025
2024
ASSETS
Current assets:
Cash and cash equivalents
$
11,821
$
8,510
Short-term investments
9,968
10,184
Accounts receivable, less current expected credit loss of $106 and $106, respectively
5,635
9,368
Inventories, net
534
397
Prepaid expenses and other current assets
1,188
1,160
Total current assets
29,146
29,619
Property and equipment, net of accumulated depreciation of $18,947 and $18,958, respectively
4,979
5,084
Goodwill
2,116
2,116
Other intangible assets, net of accumulated amortization of $534 and $525, respectively
324
327
Right-of-use operating lease assets, net
566
585
Long-term investments
9,381
10,875
Other assets
197
191
Total assets
$
46,709
$
48,797
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
$
1,587
$
2,915
Accrued liabilities:
Operating lease liabilities - current
75
77
Employee compensation
1,286
1,248
Other accrued liabilities
1,339
1,615
Total current liabilities
4,287
5,855
Operating lease liabilities - non-current
532
548
Deferred income taxes, net
176
176
Other liabilities
276
263
Total liabilities
5,271
6,842
Stockholders' equity:
Common stock, $.01 par value, 40,000,000 shares authorized, 31,852,657 and 31,767,329 shares issued, and 30,769,258 and 30,708,273 shares outstanding, respectively
318
317
Additional paid-in capital
165,405
165,295
Accumulated deficit
(120,211
)
(119,472
)
Accumulated other comprehensive loss
(1,780
)
(1,915
)
Nil coupon perpetual loan notes
76
76
Treasury stock, at cost
(2,370
)
(2,346
)
Total stockholders' equity
41,438
41,955
Total liabilities and stockholders' equity
$
46,709
$
48,797
See notes to condensed consolidated financial statements.FUEL TECH, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except share and per share data)
Three Months Ended
March 31,
2025
2024
Revenues
$
6,382
$
4,957
Costs and expenses:
Cost of sales
3,423
2,928
Selling, general and administrative
3,341
3,345
Research and development
570
376
Operating loss
(952
)
(1,692
)
Interest expense
—
—
Interest income
279
311
Other (expense) income, net
(66
)
1,673
(Loss) income before income taxes
(739
)
292
Income tax expense
—
(11
)
Net (loss) income
$
(739
)
$
281
Net (loss) income per common share:
Basic net (loss) income per common share
$
(0.02
)
$
0.01
Diluted net (loss) income per common share
$
(0.02
)
$
0.01
Weighted-average number of common shares outstanding:
Basic
30,718,000
30,385,000
Diluted
30,718,000
30,756,000
See notes to condensed consolidated financial statements.FUEL TECH, INC.CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)(in thousands)
Three Months Ended
March 31,
2025
2024
Net (loss) income
$
(739
)
$
281
Other comprehensive income (loss):
Foreign currency translation adjustments
135
(143
)
Comprehensive (loss) income
$
(604
)
$
138
See notes to condensed consolidated financial statements.FUEL TECH, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands)
Three Months Ended
March 31,
2025
2024
Operating Activities
Net (loss) income
$
(739
)
$
281
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation
164
80
Amortization
9
16
Non-cash interest income on held-to-maturity securities
(50
)
(9
)
Stock-based compensation, net of forfeitures
110
104
Changes in operating assets and liabilities:
Accounts receivable
3,768
1,250
Employee retention credit receivable
—
(1,677
)
Inventory
(137
)
(99
)
Prepaid expenses, other current assets and other non-current assets
(28
)
151
Accounts payable
(1,340
)
(563
)
Accrued liabilities and other non-current liabilities
(249
)
(609
)
Net cash provided by (used in) operating activities
1,508
(1,075
)
Investing Activities
Purchases of equipment and patents
(65
)
(114
)
Purchases of debt securities
(993
)
(7,641
)
Maturities of debt securities
2,750
2,750
Net cash provided by (used in) investing activities
1,692
(5,005
)
Financing Activities
Taxes paid on behalf of equity award participants
(24
)
—
Net cash used in financing activities
(24
)
—
Effect of exchange rate fluctuations on cash
135
(116
)
Net increase (decrease) in cash and cash equivalents
3,311
(6,196
)
Cash and cash equivalents at beginning of period
8,510
17,578
Cash and cash equivalents at end of period
$
11,821
$
11,382
See notes to condensed consolidated financial statements.FUEL TECH, INC.Segment Data- Reporting Segments(in thousands)
Information about reporting segment net sales and gross margin from operations is provided below:
Air Pollution
FUEL CHEM
Three months ended March 31, 2025
Control Segment
Segment
Other
Total
Revenues from external customers
$
1,303
$
5,079
$
—
$
6,382
Cost of sales
(878
)
(2,545
)
—
(3,423
)
Gross margin
425
2,534
—
2,959
Selling, general and administrative
—
—
(3,341
)
(3,341
)
Research and development
—
—
(570
)
(570
)
Operating income (loss) from operations
$
425
$
2,534
$
(3,911
)
$
(952
)
Air Pollution
FUEL CHEM
Three months ended March 31, 2024
Control Segment
Segment
Other
Total
Revenues from external customers
$
2,318
$
2,639
$
—
$
4,957
Cost of sales
(1,428
)
(1,500
)
—
(2,928
)
Gross margin
890
1,139
—
2,029
Selling, general and administrative
—
—
(3,345
)
(3,345
)
Research and development
—
—
(376
)
(376
)
Operating income (loss) from operations
$
890
$
1,139
$
(3,721
)
$
(1,692
)FUEL TECH, INC.Geographic Segment Financial Data(in thousands)
Information concerning our operations by geographic area is provided below. Revenues are attributed to countries based on the location of the end-user. Assets are those directly associated with operations of the geographic area.
Three Months Ended
March 31,
2025
2024
Revenues:
United States
$
5,359
$
3,595
Foreign
1,023
1,362
$
6,382
$
4,957
March 31,
December 31,
2025
2024
Assets:
United States
$
42,788
$
44,430
Foreign
3,921
4,367
$
46,709
$
48,797
FUEL TECH, INC.RECONCILIATION OF GAAP NET LOSS TO EBITDA AND ADJUSTED EBITDA (in thousands)
Three Months EndedMarch 31,
2025
2024
Net (loss) income
$
(739
)
$
281
Interest income, net
(279
)
(311
)
Income tax expense
-
11
Depreciation expense
164
80
Amortization expense
9
16
EBITDA
(845
)
77
Stock compensation expense
110
104
Gain on employee retention credit
-
(1,677
)
ADJUSTED EBITDA
$
(735
)
$
(1,496
)
Adjusted EBITDA
To supplement the Company's consolidated financial statements presented in accordance with generally accepted accounting principles in the United States (GAAP), the Company has provided an Adjusted EBITDA disclosure as a measure of financial performance. Adjusted EBITDA is defined as net income (loss) before interest expense, income tax expense (benefit), depreciation expense, amortization expense, stock compensation expense, and intangible assets abandonment and building impairment. The Company's reference to these non-GAAP measures should be considered in addition to results prepared in accordance with GAAP standards, but are not a substitute for, or superior to, GAAP results.
Adjusted EBITDA is provided to enhance investors' overall understanding of the Company's current financial performance and ability to generate cash flow, which we believe is a meaningful measure for our investor and analyst communities. In many cases non-GAAP financial measures are utilized by these individuals to evaluate Company performance and ultimately determine a reasonable valuation for our common stock. A reconciliation of Adjusted EBITDA to the nearest GAAP measure of net loss has been included in the above financial table.
CONTACT:
Vince Arnone
Devin Sullivan
President and CEO
Managing Director
(630) 845-4500
The Equity Group Inc.
dsullivan@equityny.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
38 minutes ago
- Business Upturn
Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval
Glenmark Pharmaceuticals has announced the launch of zanubrutinib in India following approval by the Drugs Controller General of India (DCGI). The drug will be marketed under the brand name BRUKINSA®, developed by BeiGene (now BeOne Medicines), a global oncology company. This marks the introduction of the first Bruton's tyrosine kinase (BTK) inhibitor in India approved for the treatment of five B-cell malignancies: chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Waldenström macroglobulinemia (WM), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), and follicular lymphoma (FL). BRUKINSA is approved in over 70 countries, backed by data from clinical studies such as ALPINE, ASPEN, and SEQUOIA. These trials have demonstrated consistent clinical outcomes across various B-cell cancers. The availability of BRUKINSA in India comes at a time when blood cancers continue to impact a large number of individuals. Estimates suggest that someone is diagnosed with blood cancer every five minutes in India, with annual deaths from the disease numbering around 70,000. The treatment has shown high response rates and the ability to maintain disease control in patients with different types of B-cell malignancies. It also offers dosing flexibility, allowing for once or twice-daily administration. In the ALPINE study, BRUKINSA was compared with ibrutinib in relapsed or refractory CLL and showed a lower rate of serious cardiac events and fewer treatment discontinuations due to cardiac-related issues. With its recent regulatory approval, BRUKINSA will now be available to patients in India who are affected by challenging hematological cancers. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
2 hours ago
- Yahoo
Quantum Computing Inc. Reports First Quarter 2025 Financial Results
HOBOKEN, N.J., May 15, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today released financial results for the three-month period ended March 31, 2025. Dr. Yuping Huang, Interim Chief Executive Officer of QCi, commented, "QCi delivered solid operational and financial progress in the first quarter, strengthening our balance sheet and advancing key strategic initiatives. We completed construction during the quarter of our Quantum Photonic Chip Foundry in Tempe, Arizona, a major milestone that positions us to meet growing demand for thin film lithium niobate (TFLN) photonic chips, underscored by the announcement of a fifth purchase during the period. We're encouraged by our early traction, which is the first step in what we believe is a significant, multi-year opportunity to serve the expanding markets in datacom, telecom, and quantum-enabled applications. In parallel, we continued to deepen engagement with both government and commercial partners, reinforcing the growing interest in our quantum and photonic machines and positioning QCi to capitalize on emerging opportunities ahead." First Quarter 2025 Financial Highlights First quarter 2025 revenues totaled approximately $39,000 (33% gross margin) compared to $27,000 (41% gross margin) generated in the first quarter of 2024. Gross margin can vary at our current revenue levels. As such, the year-over-year decrease is not unexpected. First quarter 2025 operating expenses totaled $8.3 million compared to the previous year's first quarter operating expenses of $6.3 million. The year-over-year increase was primarily driven by higher employee-based expenses. The Company reported net income attributable to common stockholders of $17.0 million, or $0.13 per basic share for the first quarter of 2025, compared to a net loss attributable to common stockholders of $6.4 million or $(0.08) per basic share for the same period of the previous year. The increase in net income this quarter was primarily due to a $23.6 million non-cash gain on the mark-to-market valuation of the Company's warrant liability as a result of our merger with QPhoton in June 2022. Total assets at March 31, 2025 were $242.5 million, increasing from $153.6 million at December 31, 2024. Cash and cash equivalents at March 31, 2025 increased by $87.5 million to $166.4 million from year-end 2024. During the first quarter, the Company raised total net proceeds of $93.6 million through a private placement offering of common stock. Total liabilities at March 31, 2025 were $21.7 million, a decrease of $24.6 million compared to year-end 2024, driven primarily by the previously-mentioned non-cash changes in the fair value of the Company's warrant liability. As of March 31, 2025, the Company had shareholders' equity totaling $220.8 million. First Quarter 2025 Operational Highlights Quantum Photonic Chip Foundry Update: During the quarter, QCi completed construction of its Quantum Photonic Chip Foundry in Tempe, Arizona, achieving a key milestone in scaling its U.S.-based TFLN manufacturing services. The Company is now establishing its process design kit (PDK) and filling customer orders. To date, the Company has received five initial orders for its foundry services. Advancing Quantum Machine Adoption: On January 15, 2025, QCi announced a collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute (Sanders TDI), a non-profit drug discovery institute comprising Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine. Through this partnership, Sanders TDI will leverage cloud-based access to QCi's Dirac-3 quantum optimization machine to support computational chemistry and biomolecular modeling research. This collaboration highlights growing adoption of QCi's quantum systems in real-world biomedical applications. Board Appointment Strengthens Strategic Leadership: On March 26, 2025, QCi appointed Eric Schwartz to its Board of Directors. Mr. Schwartz brings over 20 years of experience in corporate finance, mergers and acquisitions, and corporate strategy, with a strong track record guiding companies through commercialization and manufacturing scale-up. His expertise will support QCi's growth initiatives as the Company advances its TFLN chip foundry and drives market adoption of its quantum machines. Strengthening Sales & Market Presence: The Company continued to expand its commercial and government engagement, participating in numerous trade shows and conferences during the quarter to showcase its quantum optimization and photonic chip solutions to prospective customers and partners. Advancing Strategic Partnerships with NASA: Subsequent to the quarter on April 30, 2025, QCi was awarded a subcontract valued at approximately $406,000 through Analytical Mechanics Associates (AMA) to support NASA's Langley Research Center. Under the project, QCi will use its Dirac-3 quantum computer to develop a quantum-based technique for removing sunlight noise from space-based LIDAR data, an obstacle that has historically limited NASA's ability to conduct reliable daytime Earth observation. This project builds on QCi's prior work with NASA. Expanding Commercial Adoption of Quantum Solutions: Subsequent to the quarter, QCi secured two additional customer orders, reflecting growing global demand for its quantum machines. On April 1, 2025, the Company announced the sale of a Quantum Photonic Vibrometer to the Department of Aerospace Structures and Materials at Delft University of Technology in the Netherlands, supporting advanced research in non-destructive testing and structural health monitoring. Later in the month, on April 22, 2025, QCi announced the sale of an EmuCore reservoir computing device to a major automotive manufacturer for research and development use. These orders underscore QCi's strategy to broaden awareness and adoption of its quantum solutions across both academic and industrial markets globally. Earnings Conference Call The Company will host its first quarter conference call on Thursday, May 15, 2025, at 4:30 p.m. To access the live webcast of the conference call, visit the QCi Investor Relations page at Investors may also access the webcast via the following link: To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0011. Callers should use access code: 832763. A replay of the teleconference will be available until May 22, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 52325. About Quantum Computing Inc. Quantum Computing Inc. (Nasdaq: QUBT) is an innovative, integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. QCi's products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer unique capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications. Company Contact:Rosalyn Christian/John NesbettIMS Investor Relationsinvestors@ Forward-Looking Statements This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, generally identified by terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," "aim to," or variations of these or similar words, involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of QCi and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including the timing of orders and revenue, and the outcome of ongoing collaborations and demonstration projects with certain U.S. government agencies, academic institutions and commercial customers, and that actual results may differ materially from those contemplated by such forward-looking statements. Except as required by federal securities law, QCi undertakes no obligation to update or revise forward-looking statements to reflect changed conditions. IMPORTANT NOTICE TO USERS (summary only, click here for full text of notice): All information is unaudited unless otherwise noted or accompanied by an audit opinion and is subject to the more comprehensive information contained in our SEC reports and filings. We do not endorse third-party information. All information speaks as of the last fiscal quarter or year for which we have filed a Form 10-K or 10-Q, or for historical information the date or period expressly indicated in or with such information. We undertake no duty to update the information. Forward-looking statements are subject to risks and uncertainties described in our Forms 10-Q and 10-K. QUANTUM COMPUTING INC. Consolidated Balance Sheets (in thousands, except par value data)March 31, December 31,2025 2024Assets Current assets: Cash and cash equivalents$ 166,429 $ 78,945 Accounts receivable, net 2027 Inventory 13118 Prepaid expenses and other current assets 660161Total current assets 167,24079,151Property and equipment, net 9,9768,212Operating lease right-of-use assets 1,4191,522Intangible assets, net 8,1968,972Goodwill 55,57355,573Other non-current assets 129129Total assets$ 242,533 $ 153,559 Liabilities and Stockholders' Equity Current liabilities: Accounts payable$ 2,022 $ 1,372 Accrued expenses 6472,134 Deferred revenue 8379 Other current liabilities 990974Total current liabilities 3,7424,559Derivative liability 16,90240,532Operating lease liabilities 1,0621,181Total liabilities 21,70646,272Stockholders' equity: Common stock, $0.0001 par value, 250,000 thousand shares authorized; 137,322 thousand and 129,012 thousand shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 1413 Additional paid-in capital 404,313307,756 Accumulated deficit (183,500)(200,482)Total stockholders' equity 220,827107,287Total liabilities and stockholders' equity$ 242,533 $ 153,559 QUANTUM COMPUTING INC. Consolidated Statements of Operations (in thousands, except per share data)Three Months EndedMarch 31,2025 2024Total revenue$ 39 $ 27Cost of revenue 2616Gross profit 1311Operating expenses Research and development 2,9852,220Sales and marketing 672451General and administrative 4,6423,659Total operating expenses 8,2996,330Loss from operations (8,286)(6,319)Non-operating income (expense) Interest and other income 1,69638Interest expense, net (58)(155)Change in fair value of warrant liabilities 23,630-Income (loss) before income tax provision 16,982(6,436)Income tax provision --Net income (loss) 16,982(6,436) Net income (loss) attributable to common stockholders$ 16,982 $ (6,436) Earnings (loss) per share: Basic$ 0.13 $ (0.08)Diluted$ 0.11 $ (0.08)Weighted average shares used in computing net earnings (loss) per common share: Basic 135,21781,934Diluted 153,00681,934 View original content to download multimedia: SOURCE Quantum Computing Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Dow futures dip as stocks eye record highs ahead of U.S.-China talks and inflation reports
Stock futures ticked lower on Sunday night as the S&P 500's recent rally has brought it within 2.4% of its all-time high reached in February, before President Donald Trump's trade war ravaged markets. That comes ahead of a big week, which will see another round of U.S.-China trade talks and key inflation reports. U.S. stock futures pointed down on Sunday night ahead of a big week that will be highlighted by more U.S.-China trade talks and fresh inflation data. A strong jobs report on Friday added more fuel to a rally that has lifted the S&P 500 to within 2.4% of its all-time high reached in February, before President Donald Trump's trade war sank markets. Futures for the Dow Jones Industrial Average fell 44 points, or 0.10%. S&P 500 futures slipped 0.15%, and Nasdaq futures eased 0.23%. Tesla stock may see more downside after Trump said his relationship with CEO Elon Musk is over. The yield on the 10-year Treasury slipped less than 1 basis point to 4.506%. The dollar fell 0.11% against the euro and 0.15% against the yen. While Wall Street may not react to Trump sending National Guard troops to Los Angeles, his overall immigration crackdown represents a labor-supply shock to the economy that has implications for the dollar. Gold dipped 0.28% to $3,337.20 per ounce. U.S. oil prices climbed 0.08% to $64.63 per barrel, and Brent crude gained 0.05% to $66.50. On Monday, U.S. and Chinese officials will meet in London to begin another round of trade talks after agreeing last month in Geneva to pause their prohibitively high tariffs. Since that de-escalation in the trade war, both sides have accused the other reneging on their deal. For the U.S., a key sticking point has been the availability of rare earths, which are dominated by China and are critical for the auto, tech, and defense sectors. Kevin Hassett, director of the National Economic Council, sounded upbeat on Sunday that the London talks could result in a resolution. 'I'm very comfortable that this deal is about to be closed,' he told CBS News. Meanwhile, new inflation data are due as the Federal Reserve remains in wait-and-see mode to assess how much Trump's tariffs are moving the needle on prices. The better-than-expected jobs report on Friday eased fears of a recession, taking pressure off the Fed to cut rates to support the economy. That means that any rate cuts may have to come as a result of cooler inflation. The Labor Department will release its monthly consumer price index on Wednesday and its producer price index on Thursday. Also on Wednesday, the Treasury Department will issue its monthly update on the budget, offering clues on how much debt the federal government is issuing amid concern about bond supply and demand. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data